2027 – 2028
Radiation Oncology Residency Match & Final Clinical Year
Preparing for the 2027–2028 ERAS Radiation Oncology Match (alongside PGY-1 Transitional / Preliminary tracks) while completing U.S. clinical electives, medical exams, and translational radiation physics and software platforms (Physics Hub, RankList).
2026 – 2027
Core Clinical Clerkships — Norfolk & Norwich University Hospitals NHS Foundation Trust
Completing core inpatient and outpatient rotations in Internal Medicine, Surgery, Pediatrics, Obstetrics & Gynecology, and Psychiatry at an academic UK NHS teaching hospital.
2024 – Present
MD Candidate & Founder — St. George's University & Gnostic Vampire Media LLC
Advancing medical education toward Radiation Oncology and translational oncology while launching Gnostic Vampire Media LLC (2025), authoring speculative science fiction, and developing educational and residency software tools.
2022 – 2023
Postdoctoral Research Fellow — Massachusetts General Hospital & Harvard Medical School
Investigated pancreatic ductal adenocarcinoma (PDAC) cancer-associated fibroblast (CAF) biology, stromal–immune remodeling, and primary patient-derived pulmonary organoid systems.
2022
PhD Completed & Four Peer-Reviewed Publications — University of Hawaiʻi at Mānoa
Completed doctorate in Molecular Biosciences & Bioengineering (Advisor: Dr. Peter R. Hoffmann, JABSOM) and published four peer-reviewed articles across Nature Biomedical Engineering, Journal of Biological Chemistry (first author), Journal of Leukocyte Biology, and Scientific Reports (co-first author).
2018 – 2019
MS in Biomedical Diagnostics (ASU) & CRISPR Research (WSU / UH Cancer Center)
Completed Master of Science in Biomedical Diagnostics at Arizona State University alongside CRISPR-Cas9 mouse-model engineering at Washington State University and bladder cancer diagnostic assay work at the UH Cancer Center.
2016 – 2018
Research Assistant — Wyss Institute / Harvard Medical School
Developed pathogen-capturing FcMBL biomaterial therapeutic vaccines and innate-immune modulation platforms with Drs. Michael Super, Donald Ingber, and David Mooney, culminating in a 2022 Nature Biomedical Engineering publication.
2012 – 2015
Clinical Pathology, Molecular Diagnostics & GLP Toxicology — Converge, Lahey Clinic & Toxicon
Supported CLIA molecular HPV/PCR diagnostics at Converge Diagnostic Services, anatomic and surgical pathology operations at Lahey Clinic & Medical Center, and FDA/ISO GLP/GMP preclinical medical device toxicology at Toxicon Corporation.
2006 – 2011
BS in Liberal Studies — Northeastern University
Completed undergraduate studies in Boston, establishing foundational training in biological sciences and analytical laboratory work.